426 related articles for article (PubMed ID: 15447978)
1. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
Carcinogenesis; 2005 Jan; 26(1):219-27. PubMed ID: 15447978
[TBL] [Abstract][Full Text] [Related]
2. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.
Woods CG; Burns AM; Bradford BU; Ross PK; Kosyk O; Swenberg JA; Cunningham ML; Rusyn I
Toxicol Sci; 2007 Aug; 98(2):366-74. PubMed ID: 17483499
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of rat oval cells after activation of peroxisome proliferator-activated receptor alpha43.
Kaplanski C; Pauley CJ; Griffiths TG; Kawabata TT; Ledwith BJ
Cancer Res; 2000 Feb; 60(3):580-7. PubMed ID: 10676640
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol-lowering effect of bezafibrate is independent of peroxisome proliferator-activated receptor activation in mice.
Nakajima T; Tanaka N; Sugiyama E; Kamijo Y; Hara A; Hu R; Li G; Li Y; Nakamura K; Gonzalez FJ; Aoyama T
Biochem Pharmacol; 2008 Jul; 76(1):108-19. PubMed ID: 18486101
[TBL] [Abstract][Full Text] [Related]
5. Changes in liver PPARalpha mRNA expression in response to two levels of high-safflower-oil diets correlate with changes in adiposity and serum leptin in rats and mice.
Hsu SC; Huang CJ
J Nutr Biochem; 2007 Feb; 18(2):86-96. PubMed ID: 16713235
[TBL] [Abstract][Full Text] [Related]
6. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
[TBL] [Abstract][Full Text] [Related]
7. PPARalpha is a potential therapeutic target of drugs to treat circadian rhythm sleep disorders.
Shirai H; Oishi K; Kudo T; Shibata S; Ishida N
Biochem Biophys Res Commun; 2007 Jun; 357(3):679-82. PubMed ID: 17449013
[TBL] [Abstract][Full Text] [Related]
8. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
Goetzman ES; Tian L; Wood PA
Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes.
Tien ES; Gray JP; Peters JM; Vanden Heuvel JP
Cancer Res; 2003 Sep; 63(18):5767-80. PubMed ID: 14522898
[TBL] [Abstract][Full Text] [Related]
10. Cell cross-talk mediates PPARalpha null hepatocyte proliferation after peroxisome proliferator exposure.
Weglarz TC; Sandgren EP
Carcinogenesis; 2004 Jan; 25(1):107-12. PubMed ID: 14514660
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor alpha (PPARalpha) activators induce hepatic farnesyl diphosphate synthase gene expression in rodents.
Le Jossic-Corcos C; Pastori GM; Duclos S; Kawabe Y; Pineau T; Bournot P
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):203-11. PubMed ID: 15084352
[TBL] [Abstract][Full Text] [Related]
12. Activation of peroxisome proliferator-activated receptor alpha enhances apoptosis in the mouse liver.
Xiao S; Anderson SP; Swanson C; Bahnemann R; Voss KA; Stauber AJ; Corton JC
Toxicol Sci; 2006 Aug; 92(2):368-77. PubMed ID: 16687391
[TBL] [Abstract][Full Text] [Related]
13. Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level.
Hiuge A; Tenenbaum A; Maeda N; Benderly M; Kumada M; Fisman EZ; Tanne D; Matas Z; Hibuse T; Fujita K; Nishizawa H; Adler Y; Motro M; Kihara S; Shimomura I; Behar S; Funahashi T
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):635-41. PubMed ID: 17194889
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor alpha-independent peroxisome proliferation.
Zhang X; Tanaka N; Nakajima T; Kamijo Y; Gonzalez FJ; Aoyama T
Biochem Biophys Res Commun; 2006 Aug; 346(4):1307-11. PubMed ID: 16806075
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage.
Nakajima T; Kamijo Y; Tanaka N; Sugiyama E; Tanaka E; Kiyosawa K; Fukushima Y; Peters JM; Gonzalez FJ; Aoyama T
Hepatology; 2004 Oct; 40(4):972-80. PubMed ID: 15382117
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of bicyclol on tetracycline-induced fatty liver in mice.
Yu HY; Wang BL; Zhao J; Yao XM; Gu Y; Li Y
Toxicology; 2009 Jul; 261(3):112-8. PubMed ID: 19427351
[TBL] [Abstract][Full Text] [Related]
17. Induction of intestinal peptide transporter 1 expression during fasting is mediated via peroxisome proliferator-activated receptor alpha.
Shimakura J; Terada T; Saito H; Katsura T; Inui K
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G851-6. PubMed ID: 16751172
[TBL] [Abstract][Full Text] [Related]
18. Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent.
Barclay TB; Peters JM; Sewer MB; Ferrari L; Gonzalez FJ; Morgan ET
J Pharmacol Exp Ther; 1999 Sep; 290(3):1250-7. PubMed ID: 10454501
[TBL] [Abstract][Full Text] [Related]
19. Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation.
Nanji AA; Dannenberg AJ; Jokelainen K; Bass NM
J Pharmacol Exp Ther; 2004 Jul; 310(1):417-24. PubMed ID: 15016835
[TBL] [Abstract][Full Text] [Related]
20. Bezafibrate induces plasminogen activator inhibitor-1 gene expression in a CLOCK-dependent circadian manner.
Oishi K; Koyanagi S; Matsunaga N; Kadota K; Ikeda E; Hayashida S; Kuramoto Y; Shimeno H; Soeda S; Ohdo S
Mol Pharmacol; 2010 Jul; 78(1):135-41. PubMed ID: 20400680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]